文献速递心律失常

性别与房颤治疗方式对患者报告结局的影响

Association of sex and atrial fibrillation therapies with patient-reported outcomes.
PubMed 文献 · Heart · 2019-05-22

该研究纳入953例房颤患者,65%为男性,93%为白人,平均年龄72岁。通过倾向匹配队列分析发现,女性与更差的房颤症状严重程度、生活质量、功能状态及更高焦虑抑郁相关,且该关联在调整房颤治疗后仍存在;仅接受率控制治疗与较差的生活质量和功能状态相关。

要点

  • 女性房颤患者报告更差的症状严重程度、生活质量、功能状态及更高焦虑抑郁。
  • 调整房颤治疗后,性别与患者报告结局的关联依然存在。
  • 仅接受率控制治疗与较差的房颤相关生活质量和功能状态相关。

核心结论

  • 女性与较差的房颤症状严重程度和生活质量相关,该关联在考虑房颤治疗后仍存在。
  • 仅接受率控制药物治疗与较差的房颤相关生活质量和功能状态相关。

研究设计与样本

  • 多中心前瞻性队列研究,纳入953例年龄≥18岁的房颤患者,来自四个学术医疗中心。
  • 通过每半年一次的调查评估患者报告结局,采用倾向匹配队列进行多元线性回归分析。

主要发现

  • 接受率控制治疗者报告较低的房颤相关生活质量(-7.22,95% CI -11.51至-2.92)和较差的功能状态(-3.69,95% CI -5.27至-2.12)。
  • 接受节律控制策略者未报告显著不同的患者报告结局。
  • 女性更可能报告较差的功能状态(-2.63,95% CI -3.86至-1.40)、较高的焦虑(2.33,95% CI 1.07至3.59)、较高的抑郁症状(1.48,95% CI 0.31至2.65)和房颤症状严重程度(0.29,95% CI 0.07至0.52)。

临床怎么用

  • 临床评估房颤患者时应关注性别差异对症状和生活质量的影响。
  • 对于接受率控制治疗的患者,需注意其生活质量和功能状态可能较差。

局限性

  • 研究人群以白人为主(93%),可能限制结果的普遍性。
  • 观察性设计无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Women report higher atrial fibrillation (AF) symptom severity and receive less AF therapies than their male counterparts. It is understudied if differences in AF therapies received explains sex differences in AF symptom severity. We investigate the impact of sex and AF therapies on patient-reported outcomes. METHODS: Participants were recruited (n=953) across four academic medical centres with an AF diagnosis and age ≥18 years. Patient-reported outcomes (AF symptom severity, AF-related quality of life, functional status and emotional status) were determined by biannual surveys. We performed multiple linear regressions on propensity-matched cohorts to determine the association of AF therapies and sex on patient-reported outcomes. RESULTS: Our study population (n=953) was 65% male (n=616), 93% white (n=890) and 72 (±10) years old. Individuals receiving rate control therapy reported comparatively lower AF-related quality of life (-7.22, 95% CI -11.51 to -2.92) and poorer functional status (-3.69, 95% CI -5.27 to -2.12). Individuals receiving rhythm control strategies did not report significantly different patient-reported outcomes. Women were more likely to report poorer functional status (-2.63, 95% CI -3.86 to -1.40) and poorer AF-related quality of life, higher anxiety (2.33, 95% CI 1.07 to 3.59), higher symptoms of depression (1.48, 95% CI 0.31 to 2.65) and AF symptom severity (0.29, 95% CI 0.07 to 0.52). CONCLUSIONS: Female sex was associated with comparatively poorer AF symptom severity and quality of life, and this association remained after accounting for AF therapies received. Receiving rate control medication alone was associated with comparatively poorer AF-related quality of life and functional status.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Gleason KT, Dennison Himmelfarb CR, Ford DE, et al. Association of sex and atrial fibrillation therapies with patient-reported outcomes. Heart. 2019. PMID: 31118198. doi:10.1136/heartjnl-2019-314881

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。